Calcium/calmodulin-dependent protein kinase IV (CaMKIV) enhances osteoclast differentiation via the up-regulation of Notch1 protein stability

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1833, Issue 1, 2013, Pages 69-79

  Choi, Yun Hee ^a   Ann, Eun Jung ^a   Yoon, Ji Hye ^a   Mo, Jung Soon ^a   Kim, Mi Yeon ^a   Park, Hee Sae ^a  

^a Chonnam National University   (South Korea)

Author keywords

CaMKIV; Fbw7; Notch1 IC; Osteoclastogenesis; Phosphorylation; Ubiquitylation

Indexed keywords

CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE IV; F BOX AND WD REPEAT DOMAIN CONTAINING 7; MUTANT PROTEIN; NOTCH1 RECEPTOR; OSTEOCLAST DIFFERENTIATION FACTOR; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVITY; GENE TARGETING; HUMAN; HUMAN CELL; MOLECULAR CLONING; MOUSE; NONHUMAN; OSTEOCLAST; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; SIGNAL TRANSDUCTION; SITE DIRECTED MUTAGENESIS; TRANSCRIPTION INITIATION; UPREGULATION;

ANIMALS; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 4; CELL DIFFERENTIATION; CELLS, CULTURED; HEK293 CELLS; HUMANS; MICE; MODELS, BIOLOGICAL; OSTEOCLASTS; PROTEIN BINDING; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN STABILITY; RANK LIGAND; RECEPTOR, NOTCH1; TRANSCRIPTION, GENETIC; UP-REGULATION;

EID: 84868584255     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2012.10.018     Document Type: Article

References (60)

1. Lacey D.L., Timms E., Tan H.L., Kelley M.J., Dunstan C.R., Burgess T., Elliott R., Colombero A., Elliott G., Scully S., Hsu H., Sullivan J., Hawkins N., Davy E., Capparelli C., Eli A., Qian Y.X., Kaufman S., Sarosi I., Shalhoub V., Senaldi G., Guo J., Delaney J., Boyle W.J. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 1998, 93:165-176.
2. Li J., Sarosi I., Yan X.Q., Morony S., Capparelli C., Tan H.L., McCabe S., Elliott R., Scully S., Van G., Kaufman S., Juan S.C., Sun Y., Tarpley J., Martin L., Christensen K., McCabe J., Kostenuik P., Hsu H., Fletcher F., Dunstan C.R., Lacey D.L., Boyle W.J. RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:1566-1571.
3. Dougall W.C., Glaccum M., Charrier K., Rohrbach K., Brasel K., De Smedt T., Daro E., Smith J., Tometsko M.E., Maliszewski C.R., Armstrong A., Shen V., Bain S., Cosman D., Anderson D., Morrissey P.J., Peschon J.J., Schuh J. RANK is essential for osteoclast and lymph node development. Genes Dev. 1999, 13:2412-2424.
4. Kong Y.Y., Yoshida H., Sarosi I., Tan H.L., Timms E., Capparelli C., Morony S., Oliveira-dos-Santos A.J., Van G., Itie A., Khoo W., Wakeham A., Dunstan C.R., Lacey D.L., Mak T.W., Boyle W.J., Penninger J.M. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 1999, 397:315-323.
5. Boyle W.J., Simonet W.S., Lacey D.L. Osteoclast differentiation and activation. Nature 2003, 423:337-342.
6. Verrecchia F., Tacheau C., Wagner E.F., Mauviel A. A central role for the JNK pathway in mediating the antagonistic activity of pro-inflammatory cytokines against transforming growth factor-beta-driven SMAD3/4-specific gene expression. J. Biol. Chem. 2003, 278:1585-1593.
7. Huang H., Ryu J., Ha J., Chang E.J., Kim H.J., Kim H.M., Kitamura T., Lee Z.H., Kim H.H. Osteoclast differentiation requires TAK1 and MKK6 for NFATc1 induction and NF-kappaB transactivation by RANKL. Cell Death Differ. 2006, 13:1879-1891.
8. Lee Z.H., Kim H.H. Signal transduction by receptor activator of nuclear factor kappa B in osteoclasts. Biochem. Biophys. Res. Commun. 2003, 305:211-214.
9. Matsuoka M., Wispriyono B., Igisu H. Increased cytotoxicity of cadmium in fibroblasts lacking c-fos. Biochem. Pharmacol. 2000, 59:1573-1576.
10. Takayanagi H., Kim S., Matsuo K., Suzuki H., Suzuki T., Sato K., Yokochi T., Oda H., Nakamura K., Ida N., Wagner E.F., Taniguchi T. RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-beta. Nature 2002, 416:744-749.
11. Takayanagi H., Kim S., Koga T., Nishina H., Isshiki M., Yoshida H., Saiura A., Isobe M., Yokochi T., Inoue J., Wagner E.F., Mak T.W., Kodama T., Taniguchi T. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev. Cell 2002, 3:889-901.
12. Ikeda F., Nishimura R., Matsubara T., Tanaka S., Inoue J., Reddy S.V., Hata K., Yamashita K., Hiraga T., Watanabe T., Kukita T., Yoshioka K., Rao A., Yoneda T. Critical roles of c-Jun signaling in regulation of NFAT family and RANKL-regulated osteoclast differentiation. J. Clin. Invest. 2004, 114:475-484.
13. Kim K., Kim J.H., Lee J., Jin H.M., Lee S.H., Fisher D.E., Kook H., Kim K.K., Choi Y., Kim N. Nuclear factor of activated T cells c1 induces osteoclast-associated receptor gene expression during tumor necrosis factor-related activation-induced cytokine-mediated osteoclastogenesis. J. Biol. Chem. 2005, 280:35209-35216.
14. Matsumoto M., Kogawa M., Wada S., Takayanagi H., Tsujimoto M., Katayama S., Hisatake K., Nogi Y. Essential role of p38 mitogen-activated protein kinase in cathepsin K gene expression during osteoclastogenesis through association of NFATc1 and PU.1. J. Biol. Chem. 2004, 279:45969-45979.
15. Sato K., Suematsu A., Nakashima T., Takemoto-Kimura S., Aoki K., Morishita Y., Asahara H., Ohya K., Yamaguchi A., Takai T., Kodama T., Chatila T.A., Bito H., Takayanagi H. Regulation of osteoclast differentiation and function by the CaMK-CREB pathway. Nat. Med. 2006, 12:1410-1416.
16. Ang E.S., Zhang P., Steer J.H., Tan J.W., Yip K., Zheng M.H., Joyce D.A., Xu J. Calcium/calmodulin-dependent kinase activity is required for efficient induction of osteoclast differentiation and bone resorption by receptor activator of nuclear factor kappa B ligand (RANKL). J. Cell. Physiol. 2007, 212:787-795.
17. Chang E.J., Ha J., Huang H., Kim H.J., Woo J.H., Lee Y., Lee Z.H., Kim J.H., Kim H.H. The JNK-dependent CaMK pathway restrains the reversion of committed cells during osteoclast differentiation. J. Cell Sci. 2008, 121:2555-2564.
18. Anderson K.A., Kane C.D. Ca2+/calmodulin-dependent protein kinase IV and calcium signaling. Biometals 1998, 11:331-343.
19. Hook S.S., Means A.R. Ca(2+)/CaM-dependent kinases: from activation to function. Annu. Rev. Pharmacol. Toxicol. 2001, 41:471-505.
20. Soderling T.R. The Ca-calmodulin-dependent protein kinase cascade. Trends Biochem. Sci. 1999, 24:232-236.
21. McKenzie G.J., Stevenson P., Ward G., Papadia S., Bading H., Chawla S., Privalsky M., Hardingham G.E. Nuclear Ca2+ and CaM kinase IV specify hormonal- and Notch-responsiveness. J. Neurochem. 2005, 93:171-185.
22. Duan L., de Vos P., Fan M., Ren Y. Notch is activated in RANKL-induced osteoclast differentiation and resorption. Front. Biosci. 2008, 13:7064-7071.
23. Fukushima H., Nakao A., Okamoto F., Shin M., Kajiya H., Sakano S., Bigas A., Jimi E., Okabe K. The association of Notch2 and NF-kappaB accelerates RANKL-induced osteoclastogenesis. Mol. Cell. Biol. 2008, 28:6402-6412.
24. Duan L., de Vos P., Fan M., Ren Y. IkappaBalpha regulates Hes1 in osteoclast differentiation and resorption. Front. Biosci. (Elite Ed.) 2010, 2:1065-1072.
25. McCright B., Gao X., Shen L., Lozier J., Lan Y., Maguire M., Herzlinger D., Weinmaster G., Jiang R., Gridley T. Defects in development of the kidney, heart and eye vasculature in mice homozygous for a hypomorphic Notch2 mutation. Development 2001, 128:491-502.
26. Xue Y., Gao X., Lindsell C.E., Norton C.R., Chang B., Hicks C., Gendron-Maguire M., Rand E.B., Weinmaster G., Gridley T. Embryonic lethality and vascular defects in mice lacking the Notch ligand Jagged1. Hum. Mol. Genet. 1999, 8:723-730.
27. Swiatek P.J., Lindsell C.E., del Amo F.F., Weinmaster G., Gridley T. Notch1 is essential for postimplantation development in mice. Genes Dev. 1994, 8:707-719.
28. Hrabe de Angelis M., McIntyre J., Gossler A. Maintenance of somite borders in mice requires the Delta homologue DII1. Nature 1997, 386:717-721.
29. Bai S., Kopan R., Zou W., Hilton M.J., Ong C.T., Long F., Ross F.P., Teitelbaum S.L. NOTCH1 regulates osteoclastogenesis directly in osteoclast precursors and indirectly via osteoblast lineage cells. J. Biol. Chem. 2008, 283:6509-6518.
30. Bray S.J. Notch signalling: a simple pathway becomes complex. Nat. Rev. Mol. Cell Biol. 2006, 7:678-689.
31. Weber J.M., Calvi L.M. Notch signaling and the bone marrow hematopoietic stem cell niche. Bone 2010, 46:281-285.
32. Kopan R., Ilagan M.X. The canonical Notch signaling pathway: unfolding the activation mechanism. Cell 2009, 137:216-233.
33. Abu-Issa R., Cavicchi S. Genetic interactions among vestigial, hairy, and Notch suggest a role of vestigial in the differentiation of epidermal and neural cells of the wing and halter of Drosophila melanogaster. J. Neurogenet. 1996, 10:239-246.
34. Bessho Y., Miyoshi G., Sakata R., Kageyama R. Hes7: a bHLH-type repressor gene regulated by Notch and expressed in the presomitic mesoderm. Genes Cells 2001, 6:175-185.
35. de Celis J.F., de Celis J., Ligoxygakis P., Preiss A., Delidakis C., Bray S. Functional relationships between Notch, Su(H) and the bHLH genes of the E(spl) complex: the E(spl) genes mediate only a subset of Notch activities during imaginal development. Development 1996, 122:2719-2728.
36. Fischer A., Schumacher N., Maier M., Sendtner M., Gessler M. The Notch target genes Hey1 and Hey2 are required for embryonic vascular development. Genes Dev. 2004, 18:901-911.
37. Jennings B., Preiss A., Delidakis C., Bray S. The Notch signalling pathway is required for Enhancer of split bHLH protein expression during neurogenesis in the Drosophila embryo. Development 1994, 120:3537-3548.
38. Jouve C., Palmeirim I., Henrique D., Beckers J., Gossler A., Ish-Horowicz D., Pourquie O. Notch signalling is required for cyclic expression of the hairy-like gene HES1 in the presomitic mesoderm. Development 2000, 127:1421-1429.
39. Leimeister C., Schumacher N., Steidl C., Gessler M. Analysis of HeyL expression in wild-type and Notch pathway mutant mouse embryos. Mech. Dev. 2000, 98:175-178.
40. Ligoxygakis P., Yu S.Y., Delidakis C., Baker N.E. A subset of notch functions during Drosophila eye development require Su(H) and the E(spl) gene complex. Development 1998, 125:2893-2900.
41. Maier M.M., Gessler M. Comparative analysis of the human and mouse Hey1 promoter: Hey genes are new Notch target genes. Biochem. Biophys. Res. Commun. 2000, 275:652-660.
42. Ohtsuka T., Ishibashi M., Gradwohl G., Nakanishi S., Guillemot F., Kageyama R. Hes1 and Hes5 as notch effectors in mammalian neuronal differentiation. EMBO J. 1999, 18:2196-2207.
43. Asagiri M., Sato K., Usami T., Ochi S., Nishina H., Yoshida H., Morita I., Wagner E.F., Mak T.W., Serfling E., Takayanagi H. Autoamplification of NFATc1 expression determines its essential role in bone homeostasis. J. Exp. Med. 2005, 202:1261-1269.
44. Bulman M.P., Kusumi K., Frayling T.M., McKeown C., Garrett C., Lander E.S., Krumlauf R., Hattersley A.T., Ellard S., Turnpenny P.D. Mutations in the human delta homologue, DLL3, cause axial skeletal defects in spondylocostal dysostosis. Nat. Genet. 2000, 24:438-441.
45. Kusumi K., Sun E.S., Kerrebrock A.W., Bronson R.T., Chi D.C., Bulotsky M.S., Spencer J.B., Birren B.W., Frankel W.N., Lander E.S. The mouse pudgy mutation disrupts Delta homologue Dll3 and initiation of early somite boundaries. Nat. Genet. 1998, 19:274-278.
46. Mastrangelo P., Mathews P.M., Chishti M.A., Schmidt S.D., Gu Y., Yang J., Mazzella M.J., Coomaraswamy J., Horne P., Strome B., Pelly H., Levesque G., Ebeling C., Jiang Y., Nixon R.A., Rozmahel R., Fraser P.E., St George-Hyslop P., Carlson G.A., Westaway D. Dissociated phenotypes in presenilin transgenic mice define functionally distinct gamma-secretases. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:8972-8977.
47. Yamada T., Yamazaki H., Yamane T., Yoshino M., Okuyama H., Tsuneto M., Kurino T., Hayashi S., Sakano S. Regulation of osteoclast development by Notch signaling directed to osteoclast precursors and through stromal cells. Blood 2003, 101:2227-2234.
48. Mo J.S., Kim M.Y., Han S.O., Kim I.S., Ann E.J., Lee K.S., Seo M.S., Kim J.Y., Lee S.C., Park J.W., Choi E.J., Seong J.Y., Joe C.O., Faessler R., Park H.S. Integrin-linked kinase controls Notch1 signaling by down-regulation of protein stability through Fbw7 ubiquitin ligase. Mol. Cell. Biol. 2007, 27:5565-5574.
49. Vincent C., Kogawa M., Findlay D.M., Atkins G.J. The generation of osteoclasts from RAW 264.7 precursors in defined, serum-free conditions. J. Bone Miner. Metab. 2009, 27:114-119.
50. Kim M.Y., Ann E.J., Mo J.S., Dajas-Bailador F., Seo M.S., Hong J.A., Jung J., Choi Y.H., Yoon J.H., Kim S.M., Choi E.J., Hoe H.S., Whitmarsh A.J., Park H.S. JIP1 binding to RBP-Jk mediates cross-talk between the Notch1 and JIP1-JNK signaling pathway. Cell Death Differ. 2010, 17:1728-1738.
51. Mo J.S., Ann E.J., Yoon J.H., Jung J., Choi Y.H., Kim H.Y., Ahn J.S., Kim S.M., Kim M.Y., Hong J.A., Seo M.S., Lang F., Choi E.J., Park H.S. Serum- and glucocorticoid-inducible kinase 1 (SGK1) controls Notch1 signaling by downregulation of protein stability through Fbw7 ubiquitin ligase. J. Cell Sci. 2011, 124:100-112.
52. Ann E.J., Kim H.Y., Choi Y.H., Kim M.Y., Mo J.S., Jung J., Yoon J.H., Kim S.M., Moon J.S., Seo M.S., Hong J.A., Jang W.G., Shore P., Komori T., Koh J.T., Park H.S. Inhibition of Notch1 signaling by Runx2 during osteoblast differentiation. J. Bone Miner. Res. 2011, 26:317-330.
53. Dovey H.F., John V., Anderson J.P., Chen L.Z., de Saint Andrieu P., Fang L.Y., Freedman S.B., Folmer B., Goldbach E., Holsztynska E.J., Hu K.L., Johnson-Wood K.L., Kennedy S.L., Kholodenko D., Knops J.E., Latimer L.H., Lee M., Liao Z., Lieberburg I.M., Motter R.N., Mutter L.C., Nietz J., Quinn K.P., Sacchi K.L., Seubert P.A., Shopp G.M., Thorsett E.D., Tung J.S., Wu J., Yang S., Yin C.T., Schenk D.B., May P.C., Altstiel L.D., Bender M.H., Boggs L.N., Britton T.C., Clemens J.C., Czilli D.L., Dieckman-McGinty D.K., Droste J.J., Fuson K.S., Gitter B.D., Hyslop P.A., Johnstone E.M., Li W.Y., Little S.P., Mabry T.E., Miller F.D., Audia J.E. Functional gamma-secretase inhibitors reduce beta-amyloid peptide levels in brain. J. Neurochem. 2001, 76:173-181.
54. Sastre M., Steiner H., Fuchs K., Capell A., Multhaup G., Condron M.M., Teplow D.B., Haass C. Presenilin-dependent gamma-secretase processing of beta-amyloid precursor protein at a site corresponding to the S3 cleavage of Notch. EMBO Rep. 2001, 2:835-841.
55. Geling A., Steiner H., Willem M., Bally-Cuif L., Haass C. A gamma-secretase inhibitor blocks Notch signaling in vivo and causes a severe neurogenic phenotype in zebrafish. EMBO Rep. 2002, 3:688-694.
56. Hubbard E.J., Wu G., Kitajewski J., Greenwald I. sel-10, a negative regulator of lin-12 activity in Caenorhabditis elegans, encodes a member of the CDC4 family of proteins. Genes Dev. 1997, 11:3182-3193.
57. Hilton M.J., Tu X., Wu X., Bai S., Zhao H., Kobayashi T., Kronenberg H.M., Teitelbaum S.L., Ross F.P., Kopan R., Long F. Notch signaling maintains bone marrow mesenchymal progenitors by suppressing osteoblast differentiation. Nat. Med. 2008, 14:306-314.
58. Engin F., Yao Z., Yang T., Zhou G., Bertin T., Jiang M.M., Chen Y., Wang L., Zheng H., Sutton R.E., Boyce B.F., Lee B. Dimorphic effects of Notch signaling in bone homeostasis. Nat. Med. 2008, 14:299-305.
59. Lai E.C. Protein degradation: four E3s for the notch pathway. Curr. Biol. 2002, 12:R74-R78.
60. Kim M.Y., Jung J., Mo J.S., Ann E.J., Ahn J.S., Yoon J.H., Park H.S. The intracellular domain of Jagged-1 interacts with Notch1 intracellular domain and promotes its degradation through Fbw7 E3 ligase. Exp. Cell Res. 2011, 317:2438-2446.